ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes

Journal of Pediatric Surgery

Volumn 45, Issue 12, 2010, Pages 2412-2418

  Hao, Wei ^a,b   Wong, Olive Y ^a,b   Liu, Xuelai ^a,b   Lee, Puiyan ^a,b   Chen, Yan ^a,b   Wong, Kenneth K Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANDONG UNIVERSITY   (China)

Author keywords

3 fatty acids (EPA); 6 fatty acids (AA); Inflammation; PNALD; TPN

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COCULTURE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIVER CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DEPRESSION, CHEMICAL; DINOPROSTONE; DRUG EVALUATION, PRECLINICAL; EICOSAPENTAENOIC ACID; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; PARENTERAL NUTRITION, TOTAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649746442     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.08.044     Document Type: Article

References (36)

1. Burnes J.U., O'Keefe S.J., and Fleming C.R. Home parenteral nutrition-a 3-year analysis of clinical and laboratory monitoring JPEN JPEM JPEM J Parenter Enteral Nutr 16 1992 327 332
2. Wesley J.R. Efficacy and safety of total parenteral nutrition in pediatric patients Mayo Clin Proc 67 1992 671 675
3. Teitelbaum D.H. Parenteral nutrition-associated cholestasis Curr Opin Pediatr 9 1997 270 275
4. Sandhu I.S., Jarvis C., and Everson G.T. Total parenteral nutrition and cholestasis Clin Liver Dis 3 1999 489 508 viii
5. Kelly D.A. Liver complications of pediatric parenteral nutrition-epidemiology Nutrition 14 1998 153 157
6. Sondheimer J.M., Asturias E., and Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition J Pediatr Gastroenterol Nutr 27 1998 131 137
7. Andorsky D.J., Lund D.P., and Lillehei C.W. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes J Pediatr 139 2001 27 33
8. Kaufman S.S., Atkinson J.B., and Bianchi A. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation Pediatr Transplant 5 2001 80 87
9. Merritt R.J. Cholestasis associated with total parenteral nutrition J Pediatr Gastroenterol Nutr 5 1986 9 22
10. Benjamin D.R. Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study Am J Clin Pathol 76 1981 276 283
11. Quigley E.M., Marsh M.N., and Shaffer J.L. Hepatobiliary complications of total parenteral nutrition Gastroenterology 104 1993 286 301
12. Briones E.R., and Iber F.L. Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention J Am Coll Nutr 14 1995 219 228
13. Beath S.V., Davies P., and Papadopoulou A. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors J Pediatr Surg 31 1996 604 606
14. Cavicchi M., Beau P., and Crenn P. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure Ann Intern Med 132 2000 525 532
15. Iyer K.R., Spitz L., and Clayton P. New insight into mechanisms of parenteral nutrition-associated cholestasis; role of plantsterols J Pediatr Surg 33 1998 1 6
16. Alwayn I.P., Gura K., and Nose V. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease Pediatr Res 57 2005 445 452
17. Calder P.C., and Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity Eur J Clin Nutr 56 Suppl 3 2002 S14 S19
18. Grimm H., Mayer K., and Mayser P. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes Br J Nutr 87 Suppl 1 2002 S59 S67
19. Tsou S.S., Chiu W.C., and Yeh C.L. Effects of omega-3 fatty acids on inflammatory mediators and splenocyte cytokine mRNA expressions in rats with polymicrobial sepsis Nutrition 24 2008 484 491
20. Diamond I.R., Sterescu A., and Pencharz P.B. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome J Pediatr Gastroenterol Nutr 48 2009 209 215
21. Ekema G., Falchetti D., and Boroni G. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids) J Pediatr Surg 43 2008 1191 1195
22. Gura K.M., Duggan C.P., and Collier S.B. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management Pediatrics 118 2006 e197 e201
23. Chung P.H.Y., Wong K.K.Y., and Wong RMS Clinical experience in managing pediatric patients with ultra short bowel syndrome using omega-3-fatty acid Eur J Pediatr Surg 20 2010 139 142
24. Kubota A., Yonekura T., and Hoki M. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience J Pediatr Surg 35 2000 1049 1051
25. Gura K.M., Lee S., and Valim C. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease Pediatrics 121 2008 e678 686
26. Grimminger F., Wahn H., and Mayer K. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation Am J Respir Crit Care Med 155 1997 513 519
27. Van Aerde J.E., Duerksen D.R., and Gramlich L. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets Pediatr Res 45 1999 202 208
28. Araya J., Rodrigo R., and Videla L.A. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease Clin Sci (Lond) 106 2004 635 643
29. Zhao Y., Joshi-Barve S., and Barve S. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation J Am Coll Nutr 23 2004 71 78
30. Aldridge C., Razzak A., and Babcock T.A. Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion J Surg Res 149 2008 296 302
31. Chu A.J., Walton M.A., and Prasad J.K. Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells J Surg Res 87 1999 217 224
32. Zhao G., Etherton T.D., and Martin K.R. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells Biochem Biophys Res Commun 336 2005 909 917
33. Weldon S.M., Mullen A.C., and Loscher C.E. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid J Nutr Biochem 18 2007 250 258
34. Wang S., Wu D., and Lamon-Fava S. In vitro fatty acid enrichment of macrophages alters inflammatory response and net cholesterol accumulation Br J Nutr 102 2009 497 501
35. Lo C.J., Chiu K.C., and Fu M. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity J Surg Res 82 1999 216 221
36. Novak T.E., Babcock T.A., and Jho D.H. NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription Am J Physiol Lung Cell Mol Physiol 284 2003 L84 L89